Ichimaru Pharcos unleashes anti-ageing HyaluGuard

Ichimaru Pharcos has launched HyaluGuard to inhibit HYBID (hyaluronan binding protein involved in hyaluronan depolymerization), which is correlated with skin sagging and wrinkle depth.

The Japanese company searched for a material that inhibits the expression of HYBID in fibroblasts and found that an extract of Artemisia capillaris flowers had this effect.

HyaluGuard inhibits the degradation of hyaluronic acid (HA) in fibroblasts and works to reduce skin sagging and wrinkle.

Past study shows that a small amount of skin HA is correlated with skin sagging index and wrinkle depth.

Unfortunately, the amount of HA decreases with aging. It is known that HA loss is caused by hyaluronidase HYAL1/2.

Recent studies revealed, in the dermis, HA is mainly degraded by HYBID, the novel HA cleavage enzyme.

See more about Ichimaru Pharcos Co Ltd

Latest Issues

Society of Cosmetic Chemists 78th Annual Scientific Meeting & Showcase

JW Marriot Los Angeles L.A. LIVE
11th - 13th December 2024

PCHi 2025

China Import and Export Fair Complex Guangzhou
19-21 February 2025